New findings reveal mRNA vaccines engage different dendritic cell subtypes to activate anti-tumor immunity, providing ...

New partnership targets foot-and-mouth disease with scalable, next-generation technology A new global collaboration is aiming to bring next-generation RNA vaccine technology into livestock health, as ...

Scientists assumed that one specific immune cell subtype was required for mRNA vaccination to activate the immune system. But ...

Nanomedicine prompts RNA to make protein-based drugs to treat diseases. Now we can fine-tune protein production by dialling ...

The Federal Medical and Biological Agency (FMBA) has received permission for the clinical use of the personalized ...

A Honolulu research team is drawing attention far beyond the islands after reporting that an experimental mRNA therapy cut ...

RNA therapies present significant opportunities in targeting a broad range of diseases through various innovative approaches, including antisense oligonucleotides, siRNAs, mRNA vaccines, and aptamers.

Vaccines play a critical role in preventing infectious diseases, but their success often depends on adjuvants—substances that ...

Brazil’s Health Minister Alexandre Padilha celebrated the strategic nature of the bilateral collaboration and highlighted ...

Several moves suggest Health Secretary Robert F. Kennedy Jr. could revive his campaign to question the safety and ...

The experimental approach, drawing on decades of research into edible vaccines, uses engineered brewer’s yeast to deliver viral antigens and was developed outside traditional clinical trials.

Over the last 30 years, scientists have experimented with ways to harness plant biology to create medications, or even deliver vaccines to animals and humans — but the science has moved away from ...